• MeSH
• biologické markery MeSH
• krevní transfuze MeSH
• lidé MeSH
• magnetická rezonanční tomografie MeSH
• management nemoci MeSH
• mutace MeSH
• mutační analýza DNA MeSH
• přetížení železem diagnóza   epidemiologie   etiologie   metabolismus   MeSH
• prevalence MeSH
• pyruvátkinasa nedostatek   MeSH
• železo metabolismus   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• dopisy MeSH

An international, multicenter registry was established to collect retrospective and prospective clinical data on patients with pyruvate kinase (PK) deficiency, the most common glycolytic defect causing congenital nonspherocytic hemolytic anemia. Medical history and laboratory and radiologic data were retrospectively collected at enrollment for 254 patients with molecularly confirmed PK deficiency. Perinatal complications were common, including anemia that required transfusions, hyperbilirubinemia, hydrops, and prematurity. Nearly all newborns were treated with phototherapy (93%), and many were treated with exchange transfusions (46%). Children age 5 years and younger were often transfused until splenectomy. Splenectomy (150 [59%] of 254 patients) was associated with a median increase in hemoglobin of 1.6 g/dL and a decreased transfusion burden in 90% of patients. Predictors of a response to splenectomy included higher presplenectomy hemoglobin (P = .007), lower indirect bilirubin (P = .005), and missense PKLR mutations (P = .0017). Postsplenectomy thrombosis was reported in 11% of patients. The most frequent complications included iron overload (48%) and gallstones (45%), but other complications such as aplastic crises, osteopenia/bone fragility, extramedullary hematopoiesis, postsplenectomy sepsis, pulmonary hypertension, and leg ulcers were not uncommon. Overall, 87 (34%) of 254 patients had both a splenectomy and cholecystectomy. In those who had a splenectomy without simultaneous cholecystectomy, 48% later required a cholecystectomy. Although the risk of complications increases with severity of anemia and a genotype-phenotype relationship was observed, complications were common in all patients with PK deficiency. Diagnostic testing for PK deficiency should be considered in patients with apparent congenital hemolytic anemia and close monitoring for iron overload, gallstones, and other complications is needed regardless of baseline hemoglobin. This trial was registered at www.clinicaltrials.gov as #NCT02053480.

• MeSH
• aktivace enzymů MeSH
• cholecystektomie škodlivé účinky   metody   MeSH
• dítě MeSH
• dospělí MeSH
• fenotyp MeSH
• genetické asociační studie * MeSH
• genotyp MeSH
• hemolytická nesférocytická kongenitální anemie diagnóza   etiologie   metabolismus   terapie   MeSH
• kojenec MeSH
• kombinovaná terapie MeSH
• krevní transfuze MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• mutace MeSH
• novorozenec MeSH
• předškolní dítě MeSH
• pyruvátkinasa nedostatek   metabolismus   MeSH
• splenektomie škodlivé účinky   metody   MeSH
• určení symptomu MeSH
• vrozené poruchy metabolismu pyruvátu diagnóza   etiologie   metabolismus   terapie   MeSH
• výsledek terapie MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• kojenec MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• novorozenec MeSH
• předškolní dítě MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• multicentrická studie MeSH
• práce podpořená grantem MeSH

• MeSH
• antikoagulancia MeSH
• dítě MeSH
• fibrinolytika MeSH
• hemostáza MeSH
• trombóza MeSH
• Check Tag
• dítě MeSH
• Publikační typ
• příručky MeSH

• Konspekt
• Patologie. Klinická medicína
• NLK Obory
• hematologie a transfuzní lékařství